Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02216500 · ClinicalTrials.gov registry record · NA

Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

A NA study of Seizures, sponsored by University of Florida.

Recruiting
Registry status
NA
Development phase
400
Enrollment target
1
Study location

NCT02216500 is a NA study of Seizures that is actively recruiting participants, run by University of Florida. The registered enrollment target is 400 participants, below the 924-participant average among 39 other Seizures trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02216500, a NA study of Seizures, is actively recruiting participants, sponsored by University of Florida.

RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
1
Study location

Study Summary

Approximately a fourth of children with seizures do not respond adequately to available therapy. Ketogenic therapy has a long history as treatment for intractable epilepsy, but there is no agreement concerning how it works and what is the best way to administer it. This natural history study will collect data pertaining to both questions.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Ketogenic Therapy

Study Locations (1)

Florida

  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2006-09
Est. Completion 2031-10
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT02216500

The ClinicalTrials.gov registry entry for NCT02216500 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 924-participant average among 39 other Seizures trials with a reported enrollment target (57% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Seizures appearing as the primary indexed condition, and to 1 intervention - of which Ketogenic Therapy is the first listed.

NCT02216500 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT02216500 about?

NCT02216500 is a clinical study titled "Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy". Approximately a fourth of children with seizures do not respond adequately to available therapy. Ketogenic therapy has a long history as treatment for intractable epilepsy, but there is no agreement concerning how it works and what is the best way to administer it. This natural history study will co...

What is the current status of trial NCT02216500?

This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2006-09. Estimated completion is 2031-10.

What conditions does trial NCT02216500 study?

This clinical trial studies the following conditions: Seizures.

What interventions are being tested in trial NCT02216500?

The interventions under investigation include: Ketogenic Therapy (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02216500?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02216500 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Seizures

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.